The pharmaceutical industry is under increased pressure from several angles: more conservative regulators, shorter patent lives and challenged market access are all narrowing the window for monetizing products. Savvy consumers, physician marketing regulation, generic competition and changes to manage care are all contributing to a difficult marketing environment requiring companies to take a holistic integrated view of the marketing chain.

To address pressures on marketing budgets, marketers need to take an integrated view of marketing and sales to answer critical questions about marketing ROI and efficiency:


Who are the highest value potential segments given size, clinical situation and response to program?


How to reach patients in a way that drives involvement, action and compliance?


How to drive physician likelihood to heed patient requests?


How to deploy channels in a cost effective way against smaller segments and how to trade these off vs. traditional detailing efforts?

Marketscience’s comprehensive analytics address such critical questions, and paves a road to sustainable and significant revenue growth.


Balancing Sales And Marketing Investments In Pharma

Scroll to Top